Iovance Biotherapeutics, Inc.

Rachunek Zysków i Strat


index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41
Rok finansowy 2014 2015 2015 2015 2015 2016 2016 2016 2016 2017 2017 2017 2017 2018 2018 2018 2018 2019 2019 2019 2019 2020 2020 2020 2020 2021 2021 2021 2021 2022 2022 2022 2022 2023 2023 2023 2023 2024 2024 2024 2024 2025
Kwartał Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1
Data 2014-12-31 2015-03-31 2015-06-30 2015-09-30 2015-12-31 2016-03-31 2016-06-30 2016-09-30 2016-12-31 2017-03-31 2017-06-30 2017-09-30 2017-12-31 2018-03-31 2018-06-30 2018-09-30 2018-12-31 2019-03-31 2019-06-30 2019-09-30 2019-12-31 2020-03-31 2020-06-30 2020-09-30 2020-12-31 2021-03-31 2021-06-30 2021-09-30 2021-12-31 2022-03-31 2022-06-30 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31 2024-06-30 2024-09-30 2024-12-31 2025-03-31
Przychód (mln) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 31 59 74 49
Przychód Δ kw/kw 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% inf% inf% inf% inf% 12969.7% 12384.9% 15189.2% 6798.5%
Marża brutto -inf% 0.0% 0.0% -inf% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -inf% -inf% -inf% -inf% -inf% -inf% 0.0% -inf% -inf% -761.34% -825.37% -2820.95% -1653.15% -18.13% 32.0% 38.2% -0.85%
Koszty i Wydatki (mln) 5 5 6 8 9 7 12 19 16 21 24 22 26 27 31 35 35 40 50 52 65 71 64 59 69 76 81 86 99 92 100 100 107 111 110 119 122 118 133 148 160 171
EBIT (mln) -5 -5 -6 -8 -9 -7 -12 -19 -16 -21 -24 -22 -26 -27 -31 -35 -35 -40 -50 -52 -65 -71 -64 -59 -69 -76 -81 -86 -99 -92 -100 -100 -107 -111 -110 -118 -121 -118 -102 -89 -87 -121
EBIT Δ kw/kw 0.0% 0.0% 0.0% 0.0% 85.6% 32.3% 82.1% 148.3% 76.3% 197.9% 101.1% 17.7% 63.7% 28.7% 33.1% 56.9% 34.0% 48.8% 59.9% 47.2% 86.3% 77.1% 26.8% 14.3% 5.3% 6.7% 28.0% 46.3% 45.1% 21.4% 22.5% 16.4% 7.6% 20.9% 10.4% 17.9% 13.3% 6.2% -7.42% -24.75% -28.60% 3.0%
EBIT (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -46254.62% -25236.89% -25156.85% -16464.62% -327.63% -152.11% -117.48% -245.76%
Przychody fiansowe (mln) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 3 3 2 0 1 1 0 0 0 0 0 0 0 0 1 2 3 3 3 3 3 3 4 10 3
Koszty finansowe (mln) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 3 0 0 0 0 0
Amortyzacja (mln) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 6 5 5 5 5 6 6 8 10 10 10 11 0 12 11
EBITDA (mln) -5 -5 -6 -7 -8 -7 -11 -19 -15 -21 -23 -22 -26 -27 -31 -35 -35 -40 -50 -51 -65 -71 -63 -59 -68 -73 -81 -82 -95 -87 -94 -94 -100 -105 -102 -105 -108 -108 -91 -89 -75 -110
EBITDA(%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -46254.62% -25236.89% -23141.49% -15079.02% -292.71% -152.11% -101.62% -223.33%
NOPLAT (mln) -5 -5 -6 -8 -9 -7 -12 -19 -16 -21 -23 -22 -26 -27 -31 -34 -33 -37 -48 -49 -64 -70 -63 -59 -68 -75 -81 -86 -99 -92 -99 -100 -105 -107 -107 -115 -118 -114 -99 -85 -77 -118
Podatek (mln) 0 0 0 0 -0 0 0 0 -0 -0 0 -0 -0 0 -0 0 -0 0 0 0 -0 0 0 -0 0 -2 -0 -5 -12 -0 -0 -5 -3 -3 -0 -1 -2 -1 -1 -2 2 -2
Zysk Netto (mln) -5 -5 -6 -8 -9 -7 -12 -19 -16 -21 -23 -22 -26 -27 -31 -34 -33 -37 -48 -49 -64 -70 -63 -59 -68 -75 -81 -86 -99 -92 -99 -100 -102 -104 -107 -114 -116 -113 -97 -84 -79 -116
Zysk netto Δ kw/kw 0.0% 0.0% 0.0% 0.0% 84.0% 29.9% 81.6% 145.7% 75.2% 200.5% 102.2% 18.1% 64.8% 28.2% 31.2% 52.7% 26.0% 39.4% 55.1% 46.3% 95.1% 88.3% 32.5% 18.4% 7.6% 8.4% 29.1% 47.0% 45.2% 21.3% 21.7% 15.7% 2.6% 13.5% 7.6% 14.2% 14.2% 8.8% -8.85% -26.56% -32.50% 2.8%
Zysk netto (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -44759.66% -24255.86% -24145.02% -15800.84% -312.16% -142.67% -106.60% -235.51%
EPS -0.13 -0.14 -0.14 -0.16 -0.2 -0.14 -0.23 -0.32 -0.25 -0.33 -0.37 -0.35 -0.36 -0.31 -0.34 -0.36 -0.27 -0.3 -0.38 -0.4 -0.5 -0.55 -0.47 -0.4 -0.47 -0.51 -0.53 -0.55 -0.63 -0.58 -0.63 -0.63 -0.62 -0.49 -0.47 -0.46 -0.45 -0.42 -0.34 -0.28 -0.27 -0.36
EPS (rozwodnione) -0.13 -0.14 -0.14 -0.16 -0.2 -0.14 -0.23 -0.32 -0.25 -0.33 -0.37 -0.35 -0.36 -0.31 -0.34 -0.36 -0.27 -0.3 -0.38 -0.4 -0.5 -0.55 -0.47 -0.4 -0.47 -0.51 -0.53 -0.55 -0.63 -0.58 -0.63 -0.63 -0.62 -0.49 -0.47 -0.46 -0.45 -0.42 -0.34 -0.28 -0.27 -0.36
Ilośc akcji (mln) 38 38 45 47 44 49 51 59 62 62 62 63 73 84 90 95 119 123 124 124 126 127 133 146 146 147 154 156 157 157 157 158 165 214 224 246 256 266 285 303 290 323
Ważona ilośc akcji (mln) 38 38 45 47 44 49 51 59 62 62 62 63 73 84 90 95 119 123 124 124 126 127 133 146 146 147 154 156 157 157 157 158 165 214 224 246 256 266 285 303 290 323
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD